Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)

Listen Now

Topics Covered

• Updates from the 47th SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors
• What’s New in the Treatment of ER, PR & HER2 Positive Breast Cancer
• Updates from SABCS on Hormone & Targeted Therapy
• Chemotherapy Updates from SABCS
• Investigational New Drugs in Clinical Trials Reported at SABCS: What’s New in Preventing & Managing Treatment Side Effects, Including Discomfort, Neuropathy & Long-Term Effects of Treatment for Breast Cancer
• Key Questions to Ask Your Health Care Team
• Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Quality-of-Life Concerns
• Questions for Our Panel of Experts

Please note the time for this workshop is 1-2 p.m. ET.

Our Panel of Experts

Kate Lathrop, MD

Associate Professor, Division of Hematology and Oncology, UT Health San Antonio, Breast Medical Oncology, Mays Cancer Center at UT Health San Antonio, Assistant Dean of Undergraduate Research, Long School of Medicine, UT Health San Antonio, Program Director, Medical Oncology and Hematology Fellowship Program, UT Health San Antonio, Program Director, San Antonio Breast Cancer Symposium (SABCS)

Adrienne G. Waks, MD

Associate Director, Clinical Research, Staff Physician, Breast Medical Oncology, Dana-Farber Cancer Institute, Instructor in Medicine, Harvard Medical School

Cassie Spector, MSW

Breast and Gynecological Cancers Program Coordinator, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on February 05, 2025.